Introduction
Extramedullary plasmacytoma (EMP) is a type of plasma cell neoplasm (PCN) that can present as a primary tumour or secondary to another PCN, such as multiple myeloma (MM). Most reports indicate that EMP commonly affects the upper respiratory tract and oral cavity. 1 Gastrointestinal manifestations are rare, particularly involvement of the small intestine. Almost all cases reported in the English language literature are primary in nature. 2 We report a rare and unusual case of a patient with a relapse of MM, presenting with small bowel obstruction due to intussusception resulting from secondary EMP, who underwent a small bowel resection.
Case presentation
BS, a 58-year-old man presented to the haematology day case unit with nausea, vomiting, abdominal distension and absolute constipation of two days duration. A week earlier he had been * Corresponding author at: Level 04, Derriford Hospital, Plymouth PL6 8DH, United Kingdom. Tel.: +44 1752 517536; fax: +44 1752 517576.
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briefly admitted for three days with similar symptoms during his fifth cycle of lenolidamide and dexamethasone, with evidence of small bowel dilatation on abdominal radiograph. During that admission he was presumed to have gastroenteritis and treated conservatively with fluids and anti-emetics. BS was diagnosed two years previously with MM, with monoclonal bands of IgA lambda light chains and multiple lytic lesions on radiological assessment. He was initially treated with cyclophosphomide, thalidomide and dexamethasone with adjuvant high dose melphalan and an autologous stem cell transplant after six months. BS relapsed with monoclonal bands of IgG Kappa six months after the transplant.
On two occasions, one year and also sixth months before this index admission, BS had similar symptoms, which resolved spontaneously at home and did not present to the medical services. On his index admission, the findings included anaemia (Haemoglobin of 11.1 g/dL) and abdominal distension. Small bowel dilatation was confirmed on abdominal X-rays. Due to failure to improve, an abdominal computed tomography (CT) scan was performed which confirmed a small bowel obstruction with an ileo-ileal intussusception in the distal ileum ( Fig. 1) .
At emergency laparotomy an ileo-ileal intussusception was confirmed as well as a nodular mass in the mesentery at the apex of the intussusception (Fig. 2) . A wedge resection of 25 cm of the small bowel and mesentery was carried out, with a hand sewn end-to-end anastomosis. All other visceral organs appeared normal.
Histology confirmed a nodule of tumour composed of malignant plasma cells (plasmablastic type) centred within the subserosal and submucosa with focal extension into the lamina propria and ulceration onto the mucosal surface. The tumour cells showed diffuse positive staining for CD138, focal staining with CD79a and lambda light chain restriction. The MIB1 proliferation index was approximately 95%. There was no serosal breach at the leading point of the intussusception noted. Two out of three identified mesenteric nodes were positive for tumour. Given the history of MM, a diagnosis of secondary EMP was made.
BS developed hospital acquired pneumonia during the postoperative period and was discharged home on postoperative day eight, with ongoing treatment with lenalidomide and dexamethasone. He was readmitted two months after surgery with nausea, abdominal distension and electrolyte disturbances. A repeat abdominal CT scan revealed widespread metastases in the paracolic gutters, omentum, hepatic serosa and the retroperitoneum. He was managed by palliative care and died 13 weeks post surgery. Fig. 2 . Instrument passed into the intussusceptum of an ileo-ileal intussusception close to nodal tumour deposit in the mesentery.
Discussion
This case is unusual on account of its rarity. Haematological malignancies are the fifth most common type of cancers in the UK and form a diverse group depending on the origin in the bone marrow derived cells. They can be broadly classified as those neoplasms of myeloid cell lines, neoplasm of lymphoid cell lines, lymphoproliferative disorders and Histiocytic/Dendritic cell neoplasm.
Plasma cell neoplasm (PCN) is a type of haematological malignancy arising as a result of monoclonal proliferation of plasma cells (lymphoid cell line) and associated with production of monoclonal proteins (M Proteins). They include monoclonal gammopathy of undetermined significance (MGUS), solitary plasmacytoma of the bone (SPB), extramedullary plasmacytoma (EMP), and multiple myeloma (MM).
EMP occurs when malignant plasmoblastic clones migrate into soft tissue and represents only 3-4% of all PCN. 1 There are two major subtypes of EMP -primary and secondary. In the primary subtype, it occurs alone in the absence of another PCN, unlike in the secondary subtype, often with MM. 1 Both primary and secondary EMP predominantly (>70%) affect the upper aero-digestive tract (nasopharynx, oropharynx, hypopharynx, larynx, trachea and oesophagus). 2, 3 Developing visceral secondary EMP involving the gastrointestinal tract in the course of MM (a monoclonal, immunoproliferative PCN of the B lymphoid cells) is extremely rare -estimated to occur in 0.9% of cases. 4 Only 17 cases of EMP affecting the ileum have been reported in the English language literature -almost all primary in nature, 1 with only three previous cases of EMP secondary to MM reported. 3, 5, 6 This case falls into the latter category of an even rarer form of secondary EMP involving the ileum leading to small bowel intussusception and obstruction.
This case highlights the need for a high index of suspicion for uncommon complications of MM. It is reasonable to assume that this patient's previous symptoms were related to secondary EMP and should have been considered in his differential diagnosis. Even so, this can be a diagnostic challenge due to susceptibility of patients to gastrointestinal infections in the presence of immunosuppressive treatment. Furthermore, patients with MM have a higher risk of pseudo-obstruction of small bowel due to secondary amyloidosis. 7 A primary EMP managed with local radiotheraphy and/or surgical resection has a good prognosis with a 15-year survival rate of 78%. 8 In cases of secondary EMP, radiotheraphy or surgery alone is insufficient and systemic therapy is required. In younger patients, the use of immunomodulatory drugs with induction agents in combination with autologus haematopoietic stem cell transplantation results in higher remission rates and overall survival. 2 The prognosis of secondary EMP with gastrointestinal involvement is unknown. However, the small number of cases reported in the literature indicates a poor prognosis. 2, 3, 5, 6, 9, 10 The role of surgery in secondary EMP is often palliative, to deal with resolvable lifethreatening emergencies and where possible to prolong life.
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